Preliminary research links low vitamin K status to worse outcomes for COVID-19 patients
COVID-19 patients with low vitamin K status tend to have worse outcomes, according to preliminary results of a study conducted by researchers in the Netherlands. The preliminary results of the study have been published on the portal preprints.org. The study, conducted by researchers from Maastricht University and Canisius - Wilhelmina Hospital in Nijmegen, included experts who have studied the effects of vitamin K2 for many years.
Clear link between low vitamin K2 and worse outcomes
Vitamin K status was assessed by measuring desphospho-uncarboxylated matrix Gla protein (dp-ucMGP; inversely related to vitamin K status) and the rate of elastin degradation by measuring desmosine. The autors included 123 patients who were admitted with COVID-19 and 184 controls.
Dp-ucMGP levels were significantly elevated in COVID-19 patients (1,673Å}1,584 pmol/L) compared to controls (536±291 pmol/L; p<0.0005). Dp-ucMGP levels were significantly higher in COVID-19 patients with unfavorable outcome compared to those with less severe disease. Furthermore, dp-ucMGP and desmosine levels were significantly associated (r=0.65; p<0.0005)
Vitamin K status was reduced in patients with COVID-19 and related to poor prognosis. Also, low vitamin K status seems to be associated with accelerated elastin degradation. An intervention trial is now needed to assess whether vitamin K administration improves outcome in patients with COVID-19.
Dofferhoff, A.S.; Piscaer, I.; Schurgers, L.J.; Walk, J.; van den Ouweland, J.M.; Hackeng, T.M.; Lux, P.; Maassen, C.; Karssemeijer, E.G.; Wouters, E.F.; Janssen, R. Reduced Vitamin K Status as A Potentially Modifiable Prognostic Risk Factor in COVID-19. Preprints 2020, 2020040457 (doi: 10.20944/preprints202004.0457.v1).